A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
D50W Indications, Dosage, Storage, Stability - Hydrous dextrose
D50W Indications, Dosage, Storage, Stability - Hydrous dextrose
INDICATIONS AND USAGE
These intravenous solutions are indicated for use in adults
and pediatric patients as sources of calories and water for hydration.
DOSAGE AND ADMINISTRATION
These solutions are for intravenous use only.
Dosage is to be directed by a physician and is dependent upon
age, weight, clinical condition of the patient and laboratory determinations.
Frequent laboratory determinations and clinical evaluation are essential to
monitor changes in blood glucose and electrolyte concentrations, and fluid and
electrolyte balance during prolonged parenteral therapy.
When a hypertonic solution is to be administered peripherally,
it should be slowly infused through a small bore needle, placed well within
the lumen of a large vein to minimize venous irritation. Carefully avoid infiltration.
Fluid administration should be based on calculated maintenance
or replacement fluid requirements for each patient.
Some additives may be incompatible. Consult with pharmacist.
When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.
Parenteral drug products should be inspected visually for particulate
matter and discoloration prior to administration, whenever solution and container
permit.
Pediatric Use
There is no specific pediatric dose. The dose is dependent
on weight, clinical condition, and laboratory results. Follow recommendations
of appropriate pediatric reference text. (See WARNINGS
and PRECAUTIONS.)
HOW SUPPLIED
Dextrose Injections USP are supplied sterile and nonpyrogenic
in EXCEL® Containers. The 1000 mL containers are packaged 12 per case, the
500 mL and 250 mL containers are packaged 24 per case.
|
NDC
|
Cat. No.
|
Size
|
|
5% Dextrose Injection USP
|
|
|
|
(Canada DIN 01924281)
|
|
|
|
0264-7510-00
|
L5100
|
1000 mL
|
|
0264-7510-10
|
L5101
|
500 mL
|
|
0264-7510-20
|
L5102
|
250 mL
|
|
10% Dextrose Injection USP
|
|
|
|
(Canada DIN 01924427)
|
|
|
|
0264-7520-00
|
L5200
|
1000 mL
|
|
0264-7520-10
|
L5201
|
500 mL
|
|
0264-7520-20
|
L5202
|
250 mL
|
Exposure of pharmaceutical products to heat should be minimized.
Avoid excessive heat. Protect from freezing. It is recommended that the product
be stored at room temperature (25°C); however, brief exposure up to 40°C does
not adversely affect the product.
Revised: February 2004 U.S. Patent No. 4,803,102
EXCEL is a registered trademark of B. Braun Medical Inc.
Made in USA
top
